DRI Healthcare Trust (TSX:DHT.UN)

Q3 2025 Dri Healthcare Trust Earnings Call Transcript

Nov 6, 2025 / 01:00 PM GMT

Release Date Price: C$15.25 (-1.29%)

Transcript

Key Points

Positve

DRI Healthcare Trust (DHTRF) reported strong financial performance in Q3 2025, with a 17% increase in adjusted EBITDA to $36.7 million.
The company successfully transitioned to an internalized structure, achieving an adjusted EBITDA margin of 84%.
DRI Healthcare Trust (DHTRF) delivered double-digit cash receipt growth, driven by strong performance from the Orserdu, Xolair, and Rydap franchises.
The acquisition of synthetic royalty streams for Velligratug and VRDN 003 is expected to provide significant long-term value, with potential market growth in thyroid eye disease treatments.
The company has a diversified portfolio across various therapeutic areas, which helps mitigate risks and supports stable cash flows.

Negative

The Bangzhou asset underperformed expectations, leading to an impairment charge due to pricing trends and competitive pressures.
Omidra royalties decreased by 13% year-over-year, impacted by the merit-based incentive payment systems program.
Vonjo royalty receipts decreased by 5% due to changes in US reimbursement and increased Part D discounts from the Inflation Reduction Act.
Investing in pre-approval drugs carries inherent risks, including potential clinical trial failures.
The company's portfolio is slightly overexposed to pre-approval assets, exceeding the previously discussed 15% weighting target.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DHT_u.TO - Dri Healthcare Trust
Q3 2025 Dri Healthcare Trust Earnings Call
Nov 06, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning ladies and gentlemen, and welcome to the DRI Healthcare Q3 2025 earnings call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during the call, you require immediate assistance, please press 0 for an operator. This call is being recorded on Thursday, November 6, 2025. I would now like to turn the conference over to Ali Hadiat. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you operator and good morning everyone and thank you for taking the time to join us

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.